ALB and neoplasm: Despite increased off-target accumulation of [177Lu]Lu-Ibu-PSMA-02 at early timepoints after injection, the tumor-to-kidney and tumor-to-liver ratios at later timepoints were higher than for other albumin-binding radioligands evaluated under the same experimental conditions (Supplementary Materials, Figure S4) [11,17].